GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS)

INR 2303.2

(-1.26%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 35.73 Billion 33.26 Billion 46.33 Billion 31.13 Billion 31.35 Billion 39.11 Billion
Total Current Assets 27.98 Billion 24.94 Billion 37.08 Billion 22.02 Billion 17.74 Billion 20.06 Billion
Cash And Short Term Investments 18.78 Billion 18.11 Billion 29.02 Billion 11.37 Billion 10.61 Billion 11.47 Billion
Cash and Cash Equivalents 860.76 Million 349.4 Million 2.86 Billion 4.05 Billion 1.04 Billion 987.76 Million
Short Term Investments 17.92 Billion 17.76 Billion 26.16 Billion 7.32 Billion 9.57 Billion 10.49 Billion
Net Receivables 3.49 Billion 1.92 Billion 2.66 Billion 5.13 Billion 2.23 Billion 3.63 Billion
Inventory 5.33 Billion 4.59 Billion 5.34 Billion 5.46 Billion 4.83 Billion 4.86 Billion
Other Current Assets 358.65 Million 300.4 Million 40.33 Million 57.22 Million 61.47 Million 83.24 Million
Total Non-Current Assets 7.75 Billion 8.32 Billion 9.25 Billion 9.1 Billion 13.6 Billion 19.05 Billion
Net PPE 3.12 Billion 3.15 Billion 3.25 Billion 3.54 Billion 8.27 Billion 13.67 Billion
Good Will And Intangible Assets 235.53 Million 340.9 Million 344.97 Million 433.64 Million 496.25 Million 655.4 Million
Good Will - -8000.00 - - - -
Intangible Assets 235.53 Million 340.9 Million 344.97 Million 433.64 Million 496.25 Million 655.4 Million
Long-Term Investments 34.18 Million -17.64 Billion -26.24 Billion -7.28 Billion 3.7 Billion -10.48 Billion
Tax Assets 1.63 Billion 1.33 Billion 1.13 Billion 1.03 Billion 1.1 Billion 622.21 Million
Other Non Current Assets 2.72 Billion 21.14 Billion 30.76 Billion 11.38 Billion 30.32 Million 14.59 Billion
Other Assets 1.00 - 208 Thousand - - -
Total Liabilities 17.96 Billion 15.85 Billion 19.7 Billion 16.14 Billion 13.14 Billion 17.71 Billion
Total Current Liabilities 15.24 Billion 13.26 Billion 16.98 Billion 13.32 Billion 10.24 Billion 14.54 Billion
Account Payables 6.24 Billion 4.27 Billion 5.7 Billion 4.64 Billion 3.57 Billion 4.05 Billion
Tax Payables 2.98 Billion 2.96 Billion 2.96 Billion 1.63 Billion 1.61 Billion 1.53 Billion
Short Term Debt 121.95 Million 120.8 Million 124.53 Million 143.76 Million 149.78 Million 4.06 Million
Deferred Revenue 75.5 Million 8.3 Billion 43.47 Million 8.36 Billion 6.34 Billion 10.33 Billion
Other Current Liabilities 8.8 Billion 562 Million 11.11 Billion 170 Million 170 Million 150.64 Million
Total Non Current Liabilities 2.71 Billion 2.58 Billion 2.71 Billion 2.81 Billion 2.9 Billion 3.17 Billion
Long-Term Debt 64.69 Million 34.6 Million 76.23 Million 202.49 Million 268.61 Million 1.77 Million
Deferred Revenue Non Current -9001.00 -181.96 Million -188.85 Million -155.7 Million -172.38 Million 22.01 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.47 Billion 2.55 Billion 2.64 Billion 2.61 Billion 2.63 Billion 22.01 Million
Other Liabilities 1.00 - - - - -
Total Equity 17.77 Billion 17.41 Billion 26.62 Billion 14.99 Billion 18.2 Billion 21.39 Billion
Stock Holders Equity 17.77 Billion 17.41 Billion 26.62 Billion 14.99 Billion 18.2 Billion 21.39 Billion
Common Stock 1.69 Billion 1.69 Billion 1.69 Billion 1.69 Billion 1.69 Billion 1.69 Billion
Retained Earnings 8.76 Billion 8.11 Billion 17.42 Billion 5.46 Billion 8.75 Billion 11.87 Billion
Accumulated other comprehensive income 7.31 Billion 7.43 Billion 7.51 Billion 7.52 Billion 7.75 Billion 7.82 Billion
Common Stock Equity 17.77 Billion 17.41 Billion 26.62 Billion 14.99 Billion 18.2 Billion 21.39 Billion
Capital Lease Obligation 64.69 Million 155.4 Million 200.76 Million 346.02 Million 416.63 Million -
Total Investments 17.96 Billion 121.1 Million 110.6 Million 40.1 Million 9.57 Billion 567 Thousand
Total Debt 186.65 Million 155.4 Million 200.76 Million 346.26 Million 418.4 Million 5.83 Million
Net Debt -674.11 Million -194 Million -2.66 Billion -3.7 Billion -629.71 Million -981.93 Million

Balance Sheet Charts